Answers are grounded in this paper and cite their sources.
Randomized controlled trial shows piroxicam preserves erythrocyte counts and reduces malnutrition in female rats with anthracene exposure, indicating potential protective effects.
The study aimed to evaluate the protective effects of piroxicam and carboplatin against anthracene-induced haematological and biochemical alterations in female rats using randomized controlled trial. Thirty-six female rats of seven weeks old that weighed 166.25 ± 26.79 g divided into six groups of six each per group were used for the study. Each of the rats of group 1, 3, 4, 5 and 6 was administered 100 mg/kg of oral anthracene, for three weeks, except group 2, which was administered 2.5 mg/kg of water. Thereafter, each rat in groups 1 and 2 was administered water, group 3 (piroxicam low dose), group 4 (carboplatin/piroxicam), group 5 (piroxicam high dose) and group 6 (carboplatin) for a period of three weeks. Blood sample (2 ml) was collected from each rat for haematology and serum biochemistry. The rats were euthanised using 100 mg/kg of sodium pentobarbitone. Body weight, packed cell volume, erythrocyte, leucocyte and neutrophil counts were significantly decreased (p < 0.05), causing emaciation, anaemia, and immunodepression. Lymphocytes, monocytes, basophils, and eosinophils were significantly increased (p < 0.05) causing immunostimulation. Urea, creatinine, aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase were significantly decreased (p < 0.05), indicating malnutrition, reduced kidney and liver functions.
No takes yet. Share an insight, caveat, or question.
Anthony et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: